| MAIT cells are activated during human viral infections B Van Wilgenburg, I Scherwitzl, EC Hutchinson, T Leng, A Kurioka, ... Nature communications 7 (1), 11653, 2016 | 477 | 2016 |
| Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara DP Webster, S Dunachie, JM Vuola, T Berthoud, S Keating, SM Laidlaw, ... Proceedings of the National Academy of Sciences 102 (13), 4836-4841, 2005 | 327 | 2005 |
| Avipoxvirus phylogenetics: identification of a PCR length polymorphism that discriminates between the two major clades S Jarmin, R Manvell, RE Gough, SM Laidlaw, MA Skinner Journal of General Virology 87 (8), 2191-2201, 2006 | 153 | 2006 |
| Glutamate-induced apoptosis results in a loss of striatal neurons in the parkinsonian rat IJ Mitchell, S Lawson, B Moser, SM Laidlaw, AJ Cooper, G Walkinshaw, ... Neuroscience 63 (1), 1-5, 1994 | 144 | 1994 |
| Enhanced CD8+ T cell immune responses and protection elicited against Plasmodium berghei malaria by prime boost immunization regimens using a novel attenuated fowlpox virus RJ Anderson, CM Hannan, SC Gilbert, SM Laidlaw, EG Sheu, S Korten, ... The Journal of Immunology 172 (5), 3094-3100, 2004 | 126 | 2004 |
| Comparison of the genome sequence of FP9, an attenuated, tissue culture-adapted European strain of Fowlpox virus, with those of virulent American and … SM Laidlaw, MA Skinner Journal of general virology 85 (2), 305-322, 2004 | 112 | 2004 |
| Fowlpox virus as a recombinant vaccine vector for use in mammals and poultry MA Skinner, SM Laidlaw, I Eldaghayes, P Kaiser, MG Cottingham Expert review of vaccines 4 (1), 63-76, 2005 | 103 | 2005 |
| Safety of recombinant fowlpox strain FP9 and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers DP Webster, S Dunachie, S McConkey, I Poulton, AC Moore, M Walther, ... Vaccine 24 (15), 3026-3034, 2006 | 89 | 2006 |
| Synthetic heparan sulfate mimetic pixatimod (PG545) potently inhibits SARS-CoV-2 by disrupting the spike–ACE2 interaction SE Guimond, CJ Mycroft-West, NS Gandhi, JA Tree, TT Le, CM Spalluto, ... ACS central science 8 (5), 527-545, 2022 | 76 | 2022 |
| Immune control and failure in HCV infection—tipping the balance LB Dustin, SB Cashman, SM Laidlaw Journal of leukocyte biology 96 (4), 535-548, 2014 | 60 | 2014 |
| Fowlpox virus encodes nonessential homologs of cellular alpha-SNAP, PC-1, and an orphan human homolog of a secreted nematode protein SM Laidlaw, MA Anwar, W Thomas, P Green, K Shaw, MA Skinner Journal of virology 72 (8), 6742-6751, 1998 | 57 | 1998 |
| TRIM21/Ro52-roles in innate immunity and autoimmune disease EL Jones, SM Laidlaw, LB Dustin Frontiers in immunology 12, 738473, 2021 | 49 | 2021 |
| SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease E Barnes, CS Goodyear, M Willicombe, C Gaskell, S Siebert, T I de Silva, ... Nature Medicine 29 (7), 1760-1774, 2023 | 41 | 2023 |
| Safety and immunogenicity of the malaria candidate vaccines FP9 CS and MVA CS in adult Gambian men EB Imoukhuede, T Berthoud, P Milligan, K Bojang, J Ismaili, S Keating, ... Vaccine 24 (42-43), 6526-6533, 2006 | 39 | 2006 |
| Vaccine S Laidlaw, M Skinner, AVS Hill, SC Gilbert, R Anderson US Patent 7,273,605, 2007 | 36 | 2007 |
| Identification and characterization of three immunodominant structural proteins of fowlpox virus D Boulanger, P Green, B Jones, G Henriquet, LG Hunt, SM Laidlaw, ... Journal of virology 76 (19), 9844-9855, 2002 | 35 | 2002 |
| Tumor necrosis factor inhibits spread of hepatitis C virus among liver cells, independent from interferons SM Laidlaw, S Marukian, RH Gilmore, SB Cashman, V Nechyporuk-Zloy, ... Gastroenterology 153 (2), 566-578. e5, 2017 | 30 | 2017 |
| Alkyne derivatives of SARS-CoV-2 main protease inhibitors including nirmatrelvir inhibit by reacting covalently with the Nucleophilic Cysteine L Brewitz, L Dumjahn, Y Zhao, CD Owen, SM Laidlaw, TR Malla, ... Journal of Medicinal Chemistry 66 (4), 2663-2680, 2023 | 29 | 2023 |
| Stop-Hcv consortium B Van Wilgenburg, I Scherwitzl, EC Hutchinson, T Leng, A Kurioka, ... MAIT cells are activated during human viral infections. Nat. Commun 7 (11653 …, 2016 | 28 | 2016 |
| Induction of a strong HIV-specific CD8+ T cell response in mice using a fowlpox virus vector expressing an HIV-1 multi-CTL-epitope polypeptide DV Blomquist, P Green, SM Laidlaw, MA Skinner, P Borrow, CA Duarte Viral immunology 15 (2), 337-356, 2002 | 27 | 2002 |
